HDAC2 and glioblastoma: The combination of TAGLN/HDAC2 blocker and natural borneol for treating GBM patients reveals that combined traditional Chinese and Western medicine enhance the delivery of sodium valproate into GBM tumors and improve preclinical efficacy.